152 related articles for article (PubMed ID: 30268109)
1. Cross-sectional increase of adherence to multidisciplinary tumor board decisions.
Hollunder S; Herrlinger U; Zipfel M; Schmolders J; Janzen V; Thiesler T; Güresir E; Schröck A; Far F; Pietsch T; Pantelis D; Thomas D; Vornholt S; Ernstmann N; Manser T; Neumann M; Funke B; Schmidt-Wolf IGH
BMC Cancer; 2018 Sep; 18(1):936. PubMed ID: 30268109
[TBL] [Abstract][Full Text] [Related]
2. Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer.
Krause A; Stocker G; Gockel I; Seehofer D; Hoffmeister A; Bläker H; Denecke T; Kluge R; Lordick F; Knödler M
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1231-1240. PubMed ID: 35394231
[TBL] [Abstract][Full Text] [Related]
3. Adherence to interdisciplinary tumor board recommendations as an expression of quality-assured patient care: results of a bicentric German analysis.
Braulke F; Kober K; Rieken S; Brand T; Hartz T; Seipke S; Asendorf T; Haier J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14775-14784. PubMed ID: 37592032
[TBL] [Abstract][Full Text] [Related]
4. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide.
El Saghir NS; Keating NL; Carlson RW; Khoury KE; Fallowfield L
Am Soc Clin Oncol Educ Book; 2014; ():e461-6. PubMed ID: 24857140
[TBL] [Abstract][Full Text] [Related]
5. Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice.
Walter J; Moeller C; Resuli B; Kauffmann-Guerrero D; Manapov F; Dinkel J; Neumann J; Kovacs J; Schneider C; Huber RM; Tufman A
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11679-11688. PubMed ID: 37402967
[TBL] [Abstract][Full Text] [Related]
6. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers.
Naessens C; Laloze J; Leobon S; Gauthier T; Lacorre A; Monteil J; Venat L; Deluche E
Future Oncol; 2023 Apr; 19(13):897-908. PubMed ID: 37232140
[TBL] [Abstract][Full Text] [Related]
7. Implementation rate and effects of multidisciplinary team meetings on decision making about radiotherapy: an observational study at a single Japanese institution.
Ichikawa M; Uematsu K; Yano N; Yamada M; Ono T; Kawashiro S; Akamatsu H; Hagiwara Y; Sato H; Nemoto K
BMC Med Inform Decis Mak; 2022 Apr; 22(1):111. PubMed ID: 35477440
[TBL] [Abstract][Full Text] [Related]
8. In Absentia: An Exploratory Study of How Patients Are Considered in Multidisciplinary Cancer Team Meetings.
Hahlweg P; Hoffmann J; Härter M; Frosch DL; Elwyn G; Scholl I
PLoS One; 2015; 10(10):e0139921. PubMed ID: 26441328
[TBL] [Abstract][Full Text] [Related]
9. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer.
Ung KA; Campbell BA; Duplan D; Ball D; David S
Asia Pac J Clin Oncol; 2016 Jun; 12(2):e298-304. PubMed ID: 24674013
[TBL] [Abstract][Full Text] [Related]
10. The role of molecular tumor boards in neuro-oncology: a nationwide survey.
Hönikl LS; Lange S; Butenschoen VM; Delbridge C; Meyer B; Combs SE; Illert AL; Schmidt-Graf F
BMC Cancer; 2024 Jan; 24(1):108. PubMed ID: 38243190
[TBL] [Abstract][Full Text] [Related]
11. Validation of team performance assessment of multidisciplinary tumor boards.
Jalil R; Akhter W; Lamb BW; Taylor C; Harris J; Green JS; Sevdalis N
J Urol; 2014 Sep; 192(3):891-8. PubMed ID: 24631109
[TBL] [Abstract][Full Text] [Related]
12. Match between therapeutic proposal in multidisciplinary tumor board and actual treatment in head and neck cancer.
Alkasbi J; Mortuaire G; Rysman B; Nicot R; Chevalier D; Mouawad F
Eur Ann Otorhinolaryngol Head Neck Dis; 2021 Sep; 138(4):247-252. PubMed ID: 33257266
[TBL] [Abstract][Full Text] [Related]
13. Concordance rates of biomarkers uPA and PAI-1 results in primary breast cancer vs. consecutive tumor board decision and therapy performed in clinical hospital routine: Results of a prospective multi-center study at certified breast centers.
Jacobs VR; Augustin D; Wischnik A; Kiechle M; Hoess C; Steinkohl O; Rack B; Kapitza T; Krase P
Breast; 2016 Oct; 29():208-12. PubMed ID: 27344290
[TBL] [Abstract][Full Text] [Related]
14. European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors.
Joneborg U; Bergamini A; Wallin E; Mangili G; Solheim O; Marquina G; Casado A; Rokkones E; Coulter J; Lok CAR; van Trommel N; Amant F; Bolze PA; Sehouli J; Han S; Kridelka F; Goffin F; Pautier P; Ray-Coquard I; Seckl M
Int J Gynecol Cancer; 2023 Oct; 33(10):1621-1626. PubMed ID: 37783481
[TBL] [Abstract][Full Text] [Related]
15. [Multidisciplinary team meetings in cancerology: setting priorities for improvement].
Guillem P; Bolla M; Courby S; Descotes JL; Laramas M; Moro-Sibilot D
Bull Cancer; 2011 Oct; 98(9):989-98. PubMed ID: 21908262
[TBL] [Abstract][Full Text] [Related]
16. Thoracic multidisciplinary tumor board routinely impacts therapeutic plans in patients with lung and esophageal cancer: a prospective cohort study.
Schmidt HM; Roberts JM; Bodnar AM; Kunz S; Kirtland SH; Koehler RP; Hubka M; Low DE
Ann Thorac Surg; 2015 May; 99(5):1719-24. PubMed ID: 25678503
[TBL] [Abstract][Full Text] [Related]
17. [Medicolegal aspects of tumor boards].
Haier J; Bergmann KO
Chirurg; 2013 Mar; 84(3):225-30. PubMed ID: 23455588
[TBL] [Abstract][Full Text] [Related]
18. [Measuring quality in the German Guideline Programme in Oncology (GGPO)—methodology and implementation].
Nothacker M; Muche-Borowski C; Kopp IB
Z Evid Fortbild Qual Gesundhwes; 2014; 108(8-9):470-80. PubMed ID: 25523845
[TBL] [Abstract][Full Text] [Related]
19. [Implementation of the German guideline for the prevention, diagnosis, treatment and follow-up of non-small cell lung cancer at the Diakoniekrankenhaus Halle/Saale].
Witzmann M; Litwinenko KP; Fischbeck O; Schütte W
Pneumologie; 2013 Dec; 67(12):683-7. PubMed ID: 24222066
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
